Assessment of PK Similarity of FYB206 in Comparison With Keytruda in Resected Stage II or III Melanoma Patients
Clinical trial NCT06551064 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06551064
- Sponsor
- Formycon AG
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2026-06-30
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.